Application of carbon nanotube in miRNAs (micro Ribonucleic Acid) inspection and cell imaging
By inserting carbon nanotubes into the membrane of liposome artificial cell, the problem of low fusion efficiency between target cells and liposome artificial cells is solved, the optimization of signal transmission and the improvement of cell imaging signal intensity is achieved, and detection in living cells is expanded Application of biomarkers.
Patent Information
- Application Number
- CN202410976485.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-20
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-07-20
AI Technical Summary
The fusion efficiency between target cells and liposome artificial cells is limited, which affects the transformation of artificial cells into target cells, target molecules into artificial cells, etc., resulting in difficulty in detecting signal probes in complex physiological environments.
By inserting carbon nanotubes into the membrane of liposome artificial cell, using them as artificial transmission channels, promoting the transmission of signals and ions, improving the signal transmission efficiency between cells, and preparing liposome artificial cells in combination with thin-film hydration method to form a A new type of fluorescent probe.
It significantly improves the fusion efficiency between liposome artificial cells and target cells, optimizes signal transmission, enhances cell imaging signal intensity, provides new tools for internal and external material exchange and signaling research, broadens the live cells scope of application of biomarkers detected in the
Smart Images

Figure CN118931532A_ABST
Abstract
Description
Technical Field
[0001] The invention discloses a strategy for enhancing cell imaging signal transmission based on embedding carbon nanotubes in artificial cells, and the application of the strategy to enhance the detection of MicroRNAs and imaging in living cells by fluorescent probes based on embedding carbon nanotubes in artificial cells. Background Art
[0002] MicroRNAs (miRNAs for short) are a class of small non-coding RNAs with a length of about 21-25 nucleotides. They play an important role in the post-transcriptional regulation of gene expression. Abnormal expression of miRNAs is closely related to various diseases, including cancer, cardiovascular disease, and neurological diseases. Therefore, miRNAs are also studied as potential diagnostic markers and therapeutic targets. Let-7a is a very important member of the miRNAs family. Let-7a plays an important regulatory role in many biological processes. It is involved in processes such as cell proliferation, differentiation, apoptosis, and stem cell development. Let-7a is also considered to be a tumor suppressor miRNA, which is downregulated or inactivated in many cancers. It inhibits the growth and metastasis of cancer cells by inhibiting some key tumor-promoting factors.
[0003] It is particularly important to detect miRNAs in living cells. By detecting miRNAs in living cells, we can monitor the dynamic changes of gene expression in real time and understand its regulatory mechanism under different physiological and pathological conditions. Detecting miRNA levels in living cells can serve as a potential biomarker for early diagnosis of diseases, prognosis assessment, and efficacy monitoring.
[0004] However, the detection of these disease biomarkers in living cells is greatly challenged by the extracellular and intracellular environments. The presence of free substances in body fluids and the complexity of biological matrices often lead to interference, inactivation and perturbation of signal molecules (such as probes). Therefore, new analytical methods that can detect biomarkers in complex physiological environments while effectively protecting signal probes from matrix-induced biosensing interference are urgently needed. Currently, many strategies have been developed to protect probes in complex matrices. These strategies include the use of functional nanomaterial-based carriers, micelle-based nanocarrier dendrimers and liposomes. Among these methods, liposome-based artificial cells have become powerful carriers for biosensing and drug delivery systems. Liposomal artificial cells have controllable structural features, such as mimicking biological membranes, and provide a universal platform for intercellular / intracellular encapsulation, protection and transportation of signal probes. Therefore, liposome-based artificial cells have attracted great interest and are considered to be a relatively independent and stable sensing platform. However, although it achieves near-perfect protection of signal probes, the fusion efficiency between target cells and liposomal artificial cells is strongly limited, affecting the transformation of artificial cells into target cells, target molecules into artificial cells, etc.
[0005] To address this challenge, there is growing interest in promoting efficient cell-to-cell molecular transfer or membrane fusion, thereby allowing rapid entry of signaling probes into cells. Many studies have adopted methods to promote the translocation of exogenous signaling probes across cell membranes, including ion channels, and cell surface modifications. In order to improve intercellular fusion and material transfer, it has been proposed to insert carbon nanotubes into lipid membranes to achieve effective drug delivery. However, it is still unclear whether artificial cells containing signaling probes can effectively transmit signals to real cells for sensing analysis.
[0006] To address the above challenges, in this work, an effective artificial cell sensing platform for enhanced signal transmission was developed, using carbon nanotube nanomaterials as an effective artificial transmission channel to promote signal and ion transmission from liposomes to cell membranes for the detection of biomarkers. Initially, we used a thin film hydration method to synthesize liposome artificial cell probes to protect the signal probes and molecules required for miRNAs detection. To enhance the transmission of these probes, ions, and molecules, we inserted carbon nanotubes (CNTs) into the artificial cell membrane. CNTs have unique properties such as large surface area and nanopore space, which can promote faster chemical reactions and stronger molecular interactions. By inserting CNTs into the liposome membrane, we achieved rapid transmission of signal molecules and probes between cells. In addition, the insertion of CNTs can also be used as an artificial ion channel to accelerate ion transport between cells. This allows signal probes and ions to cross the liposome membrane interface, fuse with neighboring cells containing the target Let-7a, and the internal probes bind to the target, enhancing the fluorescence signal to sensitively detect the target miRNAs. The artificial cell system based on carbon nanotubes inserted into liposomes acts as a protective barrier for signal probes, and the inserted carbon nanotubes promote the transmission, exchange and fusion of intercellular signals. Such a system has great potential in enhancing signal transmission between cell-cell membranes and identifying biological targets in real physiological environments. Summary of the invention
[0007] Technical problem to be solved: Since the fusion efficiency between target cells and liposome artificial cells is strongly limited, the transformation of artificial cells into target cells, target molecules into artificial cells, etc. is affected. Therefore, the present invention provides an application of carbon nanotubes in miRNAs inspection and cell imaging, using carbon nanotube nanomaterials as an effective artificial transmission channel to promote signal and ion transmission from liposome artificial cells to cell membranes. The amount of carbon nanotubes added will affect the efficiency of membrane fusion. The present invention studies the amount of carbon nanotubes added and the role of carbon nanotubes in ion channels in the entire system.
[0008] Technical solution: Application of carbon nanotubes in the preparation of fluorescent probes based on artificial cells.
[0009] The preparation method of the artificial cell in the application is as follows: first, a liposome artificial cell (ArtifCell) is synthesized by a thin film hydration method, 2-oleoyl phosphatidylcholine is weighed, and it is completely dissolved with chloroform, and the chloroform is removed by reduced pressure evaporation using a vacuum rotary evaporator, and after the organic phase forms a thin film at the bottom of a round-bottom flask, the nucleic acid chain, dye, and salt ions are dissolved in a PBS solution; the prepared PBS solution is added to the film-forming round-bottom flask, and the phospholipid membrane is eluted using an ultrasonic water bath to prepare a liposome artificial cell.
[0010] The method for inserting carbon nanotubes into artificial cells is as follows: cutting and purifying carbon nanotubes, adding purified and evenly distributed carbon nanotubes with a concentration of 0.1-0.4 mg / mL and prepared liposome artificial cells into a centrifuge tube, mixing them evenly, and culturing them in a water bath for 30 minutes to allow the components to effectively interact with each other; the final solution obtained is 0.1-0.4 mg / mL ArtifCell@CNTs.
[0011] The volume ratio of the liposome artificial cells to the carbon nanotube solution is 2:1.
[0012] The concentration of ArtifCell@CNTs is 0.4 mg / mL.
[0013] A fluorescent probe containing liposome artificial cells inserted with carbon nanotubes.
[0014] The invention discloses an application of the liposome artificial cell containing inserted carbon nanotubes in enhancing the signal transmission of cell imaging.
[0015] The fluorescent probe is used in preparing a product for detecting the content of Let-7a in living colorectal cancer cells HCT116.
[0016] A method for enhancing cell imaging signal transmission based on embedding carbon nanotubes in artificial cells, wherein the molar concentration ratio of W1, W2, SUB, magnesium ions, and THT is 1:1:2:1000:4000, wherein W1 is shown in SEQ ID NO.1, W2 is shown in SEQ ID NO.2, and SUB is shown in SEQ ID NO.3.
[0017] Beneficial effects: 1. Improve fusion efficiency: The present invention uses carbon nanotubes as artificial transmission channels, which significantly improves the fusion efficiency between liposome artificial cells and target cells, overcomes the problem of limited fusion efficiency in traditional methods, and provides a new solution for the application of artificial cells in the biomedical field.
[0018] 2. Optimize signal transmission: The addition of carbon nanotubes effectively promotes the signal and ion transmission from liposome artificial cells to cell membranes, enhances the signal intensity of cell imaging, and provides a new tool for the study of intracellular and extracellular material exchange and signal transduction.
[0019] 3. Innovative preparation method: The present invention describes in detail the process of preparing liposome artificial cells based on the thin film hydration method, and combines the carbon nanotube insertion technology to form a new type of artificial cell fluorescent probe. This method is simple to operate, has good repeatability, and is easy to use in laboratories and industrial production.
[0020] 4. Broaden the scope of application: The prepared liposome artificial cell fluorescent probe containing carbon nanotubes not only performs well in enhancing cell imaging signal transmission, but is also successfully used to detect the Let-7a content in living colorectal cancer cells HCT116, demonstrating its broad application prospects in disease diagnosis, biomarker detection and other fields.
[0021] 5. Provide strategic innovation: This invention proposes a new strategy based on embedding carbon nanotubes in artificial cells to enhance cell imaging signal transmission. By optimizing the concentration ratio of each component, more efficient and sensitive cell imaging and molecular detection are achieved, making an important contribution to the development of biomedical research and clinical diagnostic technology. BRIEF DESCRIPTION OF THE DRAWINGS
[0022] Figure 1 Characterization of artificial cells and artificial cells with carbon nanotubes inserted. (a) Transmission electron microscopy image of liposome artificial cells without carbon nanotubes inserted, (bc) Transmission electron microscopy image of artificial cells with carbon nanotubes inserted, (d) Schematic diagram of artificial cells with carbon nanotubes inserted
[0023] Figure 2 (a) is an inverted microscope image before vesicle fusion, and (b) is an inverted microscope image after vesicle fusion.
[0024] Figure 3 (a) Observation of the fusion process of artificial cells with carbon nanotubes inserted under a total internal reflection fluorescence microscope, and a negative control of the fusion process of artificial cells without carbon nanotubes inserted. (b) Schematic diagram of the fusion process of artificial cells with carbon nanotubes inserted and probe 2.
[0025] Figure 4 Figure 3 shows the fusion of artificial cells with different concentrations of carbon nanotubes. (a) Schematic diagram of artificial cells inserted with carbon nanotubes stained with phospholipid-specific rhodamine B (red) and artificial cell 2 stained with calcein (green). (b) Artificial cells inserted with carbon nanotubes stained with phospholipid-specific rhodamine B (red) and artificial cell 2 stained with calcein (green). Fusion was observed under a total internal reflection microscope.
[0026] Figure 5 (a) Schematic diagram of fluorescence quenching during signal transmission and fusion of artificial cells with and without CNTs. (b) Real-time fluorescence monitoring of signal transmission of artificial cells without CNTs and artificial cells with different concentrations of CNTs.
[0027] Figure 6 (a) Schematic diagram of embedded carbon nanotubes as artificial ion channels to accelerate ion transport. (b) The UV-visible absorption spectra of chrome black T in artificial cells with or without CNTs inserted before and after the addition of magnesium ions were measured.
[0028] Figure 7 Monitoring and detection of miRNAs in living cells by using this artificial cell strategy with carbon nanotubes inserted. (a) Fluorescence imaging of HCT 116 cells after incubation with PBS, 0.1nM, 1nM, and 10nM let-7a for 12 hours with artificial cells without carbon nanotubes inserted and artificial cells with carbon nanotubes inserted. (b) Schematic diagram of the fusion process of artificial cells with carbon nanotubes inserted and colorectal cancer cells. (c) Standard curve of the average gray value for let-7a levels drawn using the proposed artificial cell strategy with carbon nanotubes inserted. The x-axis is the content of let-7a in HCT 116 cells. DETAILED DESCRIPTION
[0029] Example 1: Preparation of probes embedded with carbon nanotubes in artificial cell membranes
[0030] (1) First, liposome artificial cells were synthesized using the thin film hydration method. 10 mg of 2-oleoylphosphatidylcholine was weighed and completely dissolved in 3 mL of chloroform. The chloroform was removed by vacuum rotary evaporation at 45°C. After the organic phase formed a thin film at the bottom of the round-bottom flask, 20 μL of 5 mM magnesium chloride, 20 μL of 5 μM W1, 20 μL of 5 μM W2, 20 μL of 10 μM SUB chain and 20 μL of 20 mM THT (thioflavin T) were dissolved in 2 mL of PBS solution, respectively, and placed in a centrifuge tube. The tube was evenly oscillated on a vortex shaker for 10 minutes to ensure that the nucleic acid chain, dye and salt ion were evenly mixed. The above-prepared PBS solution containing nucleic acid chain, dye and salt ion was added to the film-forming round-bottom flask, and the phospholipid membrane was eluted using an ultrasonic water bath to prepare an artificial cell probe. The prepared liposome artificial cell was stored in a refrigerator at 4°C overnight.
[0031] The W1 sequence is: CTCCAGATTGTACCCACCTACTACCTCA
[0032] The sequence of W2 is: AACTATACAACTAGCGACTCGTCC
[0033] The SUB sequence is:
[0034] CCGCCCAACCTGTACCCACATTGGGACGAG(rA)TCTGGAGAGGTTGGGCGGGATGG GTG
[0035] (2) Preparation of 0.1 mg / mL carbon nanotube-inserted artificial cells (ArtifCell@CNTs). The purchased carbon nanotubes were cut and purified to eliminate impurities so that the carbon nanotubes were evenly dispersed in the solution and reached an appropriate length. 1 mL of 0.1 mg / mL purified and evenly distributed carbon nanotubes and 2 mL of prepared liposome artificial cells were added to a 5 mL centrifuge tube, mechanically shaken for 10 minutes, and incubated in a 37°C water bath for 30 minutes to allow the components to interact effectively. The final solution was an artificial cell inserted with carbon nanotubes, which was stored in a refrigerator at 4°C overnight for subsequent use.
[0036] The ArtifCell@CNTs prepared in this example were characterized by transmission electron microscopy, and the results are as follows: Figure 1 shown. Figure 1 Characterization of artificial cells and artificial cells with carbon nanotubes inserted. (a) Transmission electron microscope image of liposome artificial cells without carbon nanotubes inserted, (bc) Transmission electron microscope image of artificial cells with carbon nanotubes inserted, (d) Schematic diagram of artificial cells with carbon nanotubes inserted. Figure 1 It can be seen that ArtifCell@CNTs were successfully prepared.
[0037] (3) Preparation of 0.2 mg / mL carbon nanotube-inserted artificial cells (ArtifCell@CNTs), cutting and purification of purchased carbon nanotubes to eliminate impurities, so that the carbon nanotubes are evenly dispersed in the solution and reach an appropriate length. 1 mL of 0.2 mg / mL purified and evenly distributed carbon nanotubes and 2 mL of prepared liposome artificial cells were added to a 5 mL centrifuge tube, mechanically shaken for 10 minutes, and incubated in a 37°C water bath for 30 minutes to allow the components to interact effectively. The final solution is the artificial cells inserted with carbon nanotubes, and it is stored in a refrigerator at 4°C overnight for subsequent use.
[0038] (4) Preparation of 0.4 mg / mL carbon nanotube-inserted artificial cells (ArtifCell@CNTs), cutting and purification of purchased carbon nanotubes to eliminate impurities, so that the carbon nanotubes are evenly dispersed in the solution and reach an appropriate length. 1 mL of 0.4 mg / mL purified and evenly distributed carbon nanotubes and 2 mL of prepared liposome artificial cells were added to a 5 mL centrifuge tube, mechanically shaken for 10 minutes, and incubated in a 37°C water bath for 30 minutes to allow the components to interact effectively. The final solution is the artificial cells inserted with carbon nanotubes, and it is stored in a refrigerator at 4°C overnight for subsequent use.
[0039] The ArtifCell and ArtifCell@CNTs prepared in this example were characterized by fluorescence inverted microscopy and fluorescence analysis. The results are as follows: Figure 2 , Figure 3 and Figure 5 shown. Figure 2 (a) is an inverted microscope image before vesicle fusion, and (b) is an inverted microscope image after vesicle fusion. Figure 3 (a) Observation of the fusion process of artificial cells with carbon nanotubes inserted under a total internal reflection fluorescence microscope, as a negative control for observing the fusion process of artificial cells without carbon nanotubes inserted. (b) Schematic diagram of the fusion process of artificial cells with carbon nanotubes inserted and probe 2. Figure 5 (a) Schematic diagram of fluorescence quenching during signal transmission and fusion of artificial cells with and without CNTs. (b) Real-time fluorescence monitoring of signal transmission of artificial cells without CNTs and artificial cells with different concentrations of CNTs. Figure 2 It can be seen that carbon nanotubes can promote and accelerate the fusion of liposomes. Figure 3 Compared with the negative control of artificial cells without carbon nanotubes, artificial cells with carbon nanotubes can bind to liposomes faster and accelerate signal transmission. Figure 5 It can be seen that after inserting carbon nanotubes, the material exchange inside the artificial cells was effectively increased. From this, it can be inferred that carbon nanotubes can be used as material transportation channels.
[0040] Example 2: Inserting carbon nanotubes into artificial cells to accelerate fusion and signal transmission
[0041] (5) After the above materials were prepared, the signal transduction and fusion abilities of the liposome artificial cells after CNTs insertion at different concentrations (0, 0.1, 0.2, and 0.4 mg / mL) were evaluated. The artificial cells inserted with carbon nanotubes were stained with phospholipid-specific rhodamine B (red), and the artificial cells containing the target were stained with calcein (green). The fusion of the two artificial cells was observed under a total internal reflection microscope (TIRFM, Olympus, IX73, Japan).
[0042] The ArtifCell@CNTs with three carbon nanotube concentrations prepared in this example were characterized by fluorescence inverted microscopy. Figure 4 As shown, Figure 4 The fusion of artificial cells with different concentrations of carbon nanotubes. (a) Schematic diagram of artificial cells inserted with carbon nanotubes stained with phospholipid-specific rhodamine B (red) and artificial cell 2 stained with calcein (green). (b) Artificial cells inserted with carbon nanotubes stained with phospholipid-specific rhodamine b (red), and artificial cell 2 stained with calcein (green). The fusion was observed under a total internal reflection microscope. Figure 4 It shows that when carbon nanotubes with a concentration of 0.4 mg / mL are inserted into the surface of artificial cells, the liposome fusion rate is the fastest and the fusion effect is better, which is beneficial to signal transmission.
[0043] Example 3: Inserting carbon nanotubes into artificial cells to accelerate ion transport
[0044] (6) In order to analyze the role of embedded CNTs as artificial ion channels to enhance ion transport, the transport of magnesium ions from the outside to the inside of CNTs-embedded liposome artificial cells (ArtifCell@CNTs) was measured using chromium black T as an indicator. First, during the process of liposome artificial cells (ArtifCells), a solution of 0.1 mM chromium black T (pH = 10) was embedded in the artificial cells. Then, CNTs were embedded on the surface of the artificial cells. Then, a 10 mM MgCl2 solution was added to the solution, and the UV spectrum of the solution was measured. Changes in the UV spectrum indicate the concentration of ions entering the artificial cells.
[0045] The ArtifCell@CNTs prepared in this example were subjected to UV-visible absorption spectroscopy analysis, and the results were as follows: Figure 6 As shown, Figure 6 (a) Schematic diagram of embedded carbon nanotubes as artificial ion channels to accelerate ion transport. (b) The UV-visible absorption spectra of chrome black T in artificial cells with or without CNTs inserted were measured before and after the addition of magnesium ions. Figure 6 The display verified the hypothesis that carbon nanotubes serve as ion channels and material transport channels, and the absorbance change of the group inserted with carbon nanotubes was more obvious.
[0046] Example 4: Monitoring and imaging of miRNAs in living cells
[0047] (7) Fluorescence imaging of carbon nanotubes inserted into artificial cells and living cells
[0048] HCT 116 cells were cultured in RPMI-1640 medium and placed in a CO2 incubator at 37°C, 5% CO2. Subsequently, artificial cells containing signal probes inserted into carbon nanotubes were prepared by adding nucleic acids, metal ions, and fluorescent dyes to the cell culture medium. The mixture was then incubated in a CO2 incubator for 24 hours. After the incubation period, the culture medium in the cell culture dish was carefully removed with a pipette, and the cells were gently washed with PBS buffer. Finally, the green fluorescence in HCT 116 cells was observed under an inverted fluorescence microscope (Olympus, IX73, Japan).
[0049] The ArtifCell@CNTs prepared in this example were characterized and analyzed using an inverted fluorescence microscope. Figure 7 As shown, Figure 7Monitoring and detecting miRNAs in living cells by using this artificial cell strategy inserted with carbon nanotubes. (a) Fluorescence imaging of HCT 116 cells after incubation with PBS, 0.1nM, 1nM and 10nM let-7a for 12 hours with artificial cells without carbon nanotubes and artificial cells inserted with carbon nanotubes. (b) Schematic diagram of the fusion process between artificial cells inserted with carbon nanotubes and colorectal cancer cells. (c) Standard curve of the average gray value for let-7a levels drawn using the proposed artificial cell strategy inserted with carbon nanotubes. The x-axis is the content of let-7a in HCT 116 cells. Figure 7 It shows that as the concentration of the target in the cell increases, the fluorescence intensity becomes stronger. Using the standard spike method, three concentrations of the target were added to the cells, and the fluorescence images were taken with a fluorescence inverted microscope to obtain the gray value, make a standard curve, and finally obtain the target content in HCT116.
Claims
1. Application of carbon nanotubes in the preparation of fluorescent probes based on artificial cells.
2. The use according to claim 1, characterized in that: The preparation method of the artificial cell is as follows: first, a thin film hydration method is used to synthesize liposome artificial cells (ArtifCell), 2-oleoyl phosphatidylcholine is weighed, and it is completely dissolved with chloroform, and the chloroform is removed by reduced pressure evaporation using a vacuum rotary evaporator, and after the organic phase forms a thin film at the bottom of a round-bottom flask, the nucleic acid chain, the dye, and the salt ions are dissolved in a PBS solution; the prepared PBS solution is added to the film-forming round-bottom flask, and the phospholipid membrane is eluted using an ultrasonic water bath to prepare the liposome artificial cells.
3. The use according to claim 1, characterized in that: The method for inserting carbon nanotubes into artificial cells is as follows: cutting and purifying carbon nanotubes, adding purified and evenly distributed carbon nanotubes with a concentration of 0.1-0.4 mg / mL and prepared liposome artificial cells into a centrifuge tube, mixing them evenly, and culturing them in a water bath for 30 minutes to allow the components to effectively interact with each other; the final solution obtained is 0.1-0.4 mg / mL ArtifCell@CNTs.
4. The use according to claim 3, characterized in that: The volume ratio of the liposome artificial cells to the carbon nanotube solution is 2:
1.
5. The use according to claim 3, characterized in that: The concentration of ArtifCell@CNTs was 0.4 mg / mL.
6. A fluorescent probe, characterized in that Artificial cells containing liposomes inserted with carbon nanotubes.
7. Use of the liposome artificial cell containing inserted carbon nanotubes as claimed in claim 6 in enhancing cell imaging signal transmission.
8. Use of the fluorescent probe according to claim 6 in preparing a product for detecting the content of Let-7a in living colorectal cancer cells HCT116.
9. The method of claim 1 for enhancing cell imaging signal transmission based on embedding carbon nanotubes in artificial cells, characterized in that: The molar concentration ratio of W1, W2, SUB, magnesium ion and THT is 1:1:2:1000:4000, wherein W1 is as shown in SEQ ID NO.1, W2 is as shown in SEQ ID NO.2, and SUB is as shown in SEQ ID NO.3.
Citation Information
Patent Citations
MiRNA capture probe, modifying electrode thereof, capture probe complementary strand, capture probe complementary strand modified carbon nanotube-gold magnetic nanoparticle compound
CN104152449A
Artificial cell biosensing system as well as preparation method and application thereof
CN116287228A
Application of Nano carbon tubes in biology
CN1796567A
Reversible biogel for manipulation and separation of single-walled carbon nanotubes
WO2008048352A2
